vix.ing · top · new · best · stats · spec

Takashi Nakada

  1. The Latest Research and Development into the Antibody–Drug Conjugate, [fam-] Trastuzumab Deruxtecan (DS-8201a), for HER2 Cancer Therapy
    2019/02/28 by Takashi Nakada, Kiyoshi Sugihara, Takahiro Jikoh +2 · 4 citations
    Medicine · #HER2/EGFR in Cancer Research #Monoclonal and Polyclonal Antibodies Research #Peptidase Inhibition and Analysis